Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$5.43 USD
+0.37 (7.31%)
Updated May 14, 2024 04:00 PM ET
After-Market: $5.44 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Earnings News For SYRS
-
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
-
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
-
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
-
Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Lags Revenue Estimates
-
Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates
-
Syros Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses Revenue Estimates
-
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Will Syros Pharmaceuticals, Inc. (SYRS) Report Negative Q2 Earnings? What You Should Know
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Tops Revenue Estimates
-
Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates
-
Will Syros Pharmaceuticals, Inc. (SYRS) Report Negative Q2 Earnings? What You Should Know
-
Syros Pharmaceuticals Inc (SYRS) Reports Q1 Loss, Tops Revenue Estimates
-
Will Syros Pharmaceuticals, Inc. (SYRS) Report Negative Q1 Earnings? What You Should Know